Chinese pharma company Sinovac 'confident' of vaccine safety after Brazil trial halted

  • 📰 thejournal_ie
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 50%

Business News News

Business Business Latest News,Business Business Headlines

The suspension of the trial was a blow for the firm and came on the same day as a positive announcement about the Pfizer/BioNTech trial.

Image: Wiktor Dabkowski/PA Image: Wiktor Dabkowski/PA CHINESE PHARMACEUTICAL FIRM Sinovac Biotech is standing by the safety of its Covid-19 vaccine after Brazilian regulators halted trials in the South American country citing an “adverse incident” involving a volunteer recipient.

This morning Sinovac said it is “confident in the safety of the vaccine”. The company also said the adverse incident in one of its trial volunteers was “unrelated to the vaccine”. At yesterday’s Department of Health Covid-19 briefing, Chief Medical Officer Dr Tony Holohan said it is “certainly night time for celebration” yet as the trial is not yet complete and regulatory authorities will still have to inspect the data when it is published.

“Over 90% effective – if that holds true in the real world – will be a very good start from a vaccination perspective. Obviously, it’s a two dose schedule so there’s some potential logistical challenges around that,” he said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Christ almighty I’m not taking any new vaccine .... not a chance

China is doing the plot to 'Mission Impossible 2'...... the terrible one.

Sure we have no reason to doubt China! 🤣

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 32. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

O'Gorman stresses GSK's 'moral obligation' over vaccine trials but company's position 'remains unchanged'Roderic O'Gorman stresses GSK's 'moral obligation' over vaccine trials but company's position on compensation 'remains unchanged'
Source: thejournal_ie - 🏆 32. / 50 Read more »